Dosing interval strategies for two-dose COVID-19 vaccination in 13 middle-income countries of Europe: Health impact modelling and benefit-risk analysis. (2022)
Attributed to:
The dynamics of drug resistance within hospital populations of Gram-negative bacteria
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.lanepe.2022.100381
PubMed Identifier: 35434685
Publication URI: http://europepmc.org/abstract/MED/35434685
Type: Journal Article/Review
Volume: 17
Parent Publication: The Lancet regional health. Europe
ISSN: 2666-7762